Exenatide-associated ischemic renal failure.
Weise
Wolfgang J
WJ
Sivanandy
Mala S
MS
Block
Clay A
CA
Comi
Richard J
RJ
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D003928:Diabetic Nephropathies / Q000473:pathology; D004232:Diuretics / Q000627:therapeutic use; D000077270:Exenatide; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007511:Ischemia / Q000139:chemically induced; D007678:Kidney Glomerulus / Q000098:blood supply / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000139:chemically induced*; D014688:Venoms / Q000009:adverse effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D000077270:Exenatide; D003404:Creatinine